Nordic Nanovector - Appointment of Alf Bjørseth as CEO

About Nordic Nanovector About Nordic Nanovector Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. This information is subject of the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. Ludvik Sandnes, Interim CEO & CFO Cell: +47 907 43 017 Email:  ir@nordicnanovector.com   View original content:...

About Nordic Nanovector

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.

This information is subject of the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Ludvik Sandnes, Interim CEO & CFO
Cell: +47 907 43 017
Email: ir@nordicnanovector.com

 

View original content:https://www.prnewswire.co.uk/news-releases/nordic-nanovector--appointment-of-alf-bjorseth-as-ceo-301866005.html